Two Sigma Investments, LP Adma Biologics, Inc. Transaction History

Two Sigma Investments, LP

$50.6 Billion
Q2 2025

A detailed history of Two Sigma Investments, LP transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 1,202,101 shares of ADMA stock, worth $20.1 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

1,202,101

Previous 2,255,306 46.7%

Holding current value

$20.1 Million

Previous $44.7 Million 51.08%

% of portfolio

0.04%

Previous 0.1%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$17.6 - $24.51 $18.5 Million - $25.8 Million	-1,053,205 Reduced 46.7%	1,202,101 $21.9 Million
Q1 2025 May 15, 2025	SELL	$15.44 - $20.61 $4.53 Million - $6.05 Million	-293,648 Reduced 11.52%	2,255,306 $44.7 Million
Q4 2024 Feb 14, 2025	SELL	$15.62 - $22.62 $16.3 Million - $23.6 Million	-1,042,421 Reduced 29.03%	2,548,954 $43.7 Million
Q3 2024 Nov 14, 2024	SELL	$11.21 - $20.03 $4.89 Million - $8.74 Million	-436,225 Reduced 10.83%	3,591,375 $71.8 Million
Q2 2024 Aug 14, 2024	BUY	$5.98 - $11.18 $1.09 Million - $2.03 Million	181,642 Added 4.72%	4,027,600 $45 Million
Q1 2024 May 15, 2024	BUY	$4.4 - $6.74 $3.26 Million - $4.99 Million	740,948 Added 23.86%	3,845,958 $25.4 Million
Q4 2023 Feb 14, 2024	SELL	$3.08 - $4.52 $254,820 - $373,957	-82,734 Reduced 2.6%	3,105,010 $14 Million
Q3 2023 Nov 14, 2023	BUY	$3.47 - $4.61 $1.38 Million - $1.83 Million	397,741 Added 14.26%	3,187,744 $11.4 Million
Q2 2023 Aug 14, 2023	BUY	$3.12 - $4.22 $1.46 Million - $1.98 Million	468,644 Added 20.19%	2,790,003 $10.3 Million
Q1 2023 May 15, 2023	SELL	$3.01 - $3.87 $202,046 - $259,773	-67,125 Reduced 2.81%	2,321,359 $7.68 Million
Q4 2022 Feb 14, 2023	BUY	$2.47 - $3.88 $2.62 Million - $4.12 Million	1,062,502 Added 80.13%	2,388,484 $9.27 Million
Q3 2022 Nov 14, 2022	BUY	$2.03 - $2.86 $1.55 Million - $2.19 Million	764,545 Added 136.18%	1,325,982 $3.22 Million
Q2 2022 Aug 15, 2022	BUY	$1.43 - $2.2 $802,854 - $1.24 Million	561,437 New	561,437 $1.11 Million
Q1 2020 May 15, 2020	SELL	$1.5 - $4.59 $38,179 - $116,829	-25,453 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$3.89 - $5.15 $99,012 - $131,082	25,453 New	25,453 $102,000
Q3 2019 Nov 14, 2019	SELL	$3.19 - $5.39 $173,325 - $292,860	-54,334 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$3.52 - $5.24 $191,255 - $284,710	54,334 New	54,334 $210,000

Others Institutions Holding ADMA

# of Institutions

407

Shares Held

193M

Call Options Held

2.13M

Put Options Held

1.59M

View Full List

About ADMA BIOLOGICS, INC.

Ticker ADMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 196,356,992
Market Cap $3.29B
Description
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...

More about ADMA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account

Two Sigma Investments, LP Adma Biologics, Inc. Transaction History